- Cardiopulmonary exercise testing (CPET) systems, offering comprehensive assessment of the heart, lungs, and metabolic systems during exercise, are increasingly vital components of modern diagnostic and prognostic evaluations in both clinical and research settings due to their enhanced precision, ability to detect subtle abnormalities, and seamless integration with patient management protocols
- The escalating demand for CPET is primarily fueled by the widespread adoption of advanced medical technologies, growing prevalence of cardiovascular and respiratory diseases among consumers, and a rising preference for accurate, non-invasive diagnostic tools
- North America dominates the cardiopulmonary exercise testing market with the largest revenue share of 40.01% in 2024, driven by a high prevalence of cardiovascular and pulmonary disorders and advanced healthcare infrastructure
- Asia-Pacific is expected to be the fastest growing region in the cardiopulmonary exercise testing market during the forecast period with a CAGR of 7.25%, due to increasing urbanization, rising disposable incomes, and a growing emphasis on early diagnosis and preventive healthcare
- The cardiopulmonary exercise testing (CPET) systems segment dominates the cardiopulmonary exercise testing market with a market share of 51.2% in 2024, driven by its established reputation for providing detailed insights into cardiorespiratory function and ease of integration into comprehensive diagnostic workflows
